Browse studies

Find your next paid study

27,293 recruiting studies available now

An Observational Study to Assess the Long-term Safety of Ustekinumab Versus Other Biologic Therapies Among Patients With Crohn's Disease and Ulcerative Colitis: A New-User Cohort Study Using the Department of Defense Electronic Health Records Database

The purpose of this study is to estimate and compare the incidence of overall malignancy, serious infection, and opportunistic infections between new users of …

Crohn DiseaseColitis, Ulcerative

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Janssen Scientific Affairs, LLCNCT04372108

Observational

A Phase Ib Single-Arm Study Evaluating Toxicity, Outcomes, and Dosimetry Using Adaptive Stereotactic Body Radiotherapy for the Salvage Treatment of Post-prostatectomy Prostate Cancer

The purpose of the study is to evaluate the safety and feasibility of daily-adaptive post-prostatectomy stereotactic body radiotherapy (SBRT) to the prostate f…

Prostate Adenocarcinoma

Estimated

~$10 – $1,125

Actual pay is set by the research site.

NYU Langone HealthNCT07888283

Observational

Combined Functional Electrical and Transcranial Direct Current Stimulation for Foot Drop: A Case Series

This study aims to determine if combining the treatments of transcranial direct current stimulation (tDCS) and functional electrical stimulation (FES) will bet…

FallsFoot DropPost Stroke Recovery

Estimated

~$10 – $750

Actual pay is set by the research site.

Saint Joseph's University, PhiladelphiaNCT07592221

Observational

Lipid Lowering Therapy for Atherosclerotic Disease in Melanoma Patients Receiving Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) are a class of medications that are now standard in the treatment of melanoma. These are standard therapy for melanoma, but…

Melanoma

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT07704918

Phase 2

A Phase II Study to Examine the Impact of CD22 CAR T-cells to Extend the Duration of Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Background: Acute lymphoblastic leukemia (ALL) is a type of blood cancer. Chimeric antigen receptor (CAR) therapy involves taking immune cells (T cells) from …

Acute Lymphoblastic LeukemiaB-All

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT07328503

Observational

Developing and Implementing HPV SCREENED (Self-Collection REach and ENgagement in Emergency Departments) to Improve Cancer Equity

This study will assess the feasibility of implementing HPV self-sampling as a primary cervical cancer screening strategy for under-screened women in the emerge…

Cervical Cancer ScreeningHuman Papilloma Virus

Estimated

~$10 – $750

Actual pay is set by the research site.

Rutgers, The State University of New JerseyNCT07657104

Phase 2

Propranolol With Definitive or Neoadjuvant Chemotherapy, Chemotherapy-Immunotherapy or Chemoradiation Therapy or Chemoradiation for Esophageal Adenocarcinoma A Phase II Study

This phase II trial studies the side effects and best dose of propranolol when administered concurrently with SOC neoadjuvant CRT in patients with esophageal c…

Esophageal Adenocarcinoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Roswell Park Cancer InstituteNCT04682158

Phase 1

An Open-label, Multicenter Phase 1b/2 Study to Evaluate the Safety and Efficacy of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

The study will evaluate NX-5948 (bexobrutideg) in combination with venetoclax with or without an anti-CD20 antibody (rituximab or obinutuzumab) in second-line …

B-cell LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Nurix Therapeutics, Inc.NCT07520006

Clinical Study Protocol SGi 1.0 + EPW 1.0 + Compatible Clinical Displays Clinical Validation Study

The primary objective of this study is to show safety and effectiveness of the investigational device for In Vitro Diagnostic (IVD) use as an aid to the pathol…

Pathological Processes

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Philips Digital & Computational PathologyNCT07881874

Sensor-based Congestion Alert for Events in Peritoneal Dialysis (SCALE-PD)

To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.

Kidney DiseasePeritoneal Dialysis (PD)End Stage Kidney Disease (ESRD)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Bodyport Inc.NCT07059962

Phase 1

A Phase 1a/1b Study of LY4052031, an Antibody-Drug Conjugate Targeting Nectin-4, in Participants With Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors

The purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid…

Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Eli Lilly and CompanyNCT06465069

Phase 1

A Study of a Mutant-Selective Inhibitor, CGT6297, in Patients With Advanced Solid Tumors Harboring PIK3CA Mutations

This is a Phase 1, two-part, open-label, nonrandomized, dose-escalation and signal-seeking study of CGT6297, evaluating the safety, tolerability, PK, pharmacod…

PIK3CA MutationsAdvanced Solid Tumors, AdultEndometrial Cancer+2 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Cogent Biosciences, Inc.NCT07383506